June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

July 24, 2015July 24, 2015

Georgetown University Medical Center Physician to Lead National Melanoma Clinical Trial

News

A renowned Georgetown University Medical Center physician will lead a national clinical trial involving new treatments for melanoma. The trial will compare two groups of drugs known for their efficacy ... Read more

July 22, 2015July 22, 2015

Skin Cancer Marker Plays Critical Role in Tumor Growth

News

A collaborative team of interdisciplinary researchers led by Dr. Ryan P. Hobbs, PhD, a postdoctoral fellow at John Hopkins Bloomberg School of Public Health’s Department of Biochemistry and Molecular Biology, ... Read more

July 20, 2015July 20, 2015

Effective State Indoor Tanning Regulations Could Lead To National Regulatory Framework To Curtail Skin Cancer

News, Skin Cancer

A regulatory void in urgent need of filling is establishment of a national regulatory framework for prevention and limitation of indoor tanning to help alleviate the cancer burden on the ... Read more

July 17, 2015July 17, 2015

Viagra Does Not Cause Melanoma, According to Study

News

A thorough assessment of over 20,000 medical records revealed that erectile dysfunction drugs like Viagra do not cause melanoma despite the elevated risk for the disease among those who use such drugs. The report was published in the Journal of ... Read more

July 15, 2015July 15, 2015

Novel Adoptive Immunotherapy Based on T Cells for Advanced Melanoma

News

A recent study led by researchers at the University Hospitals Case Medical Center Seidman Cancer Center reported a new promising therapeutic strategy based on adoptive immunotherapy for advanced melanoma. The ... Read more

July 10, 2015July 10, 2015

Caladrius Biosciences Doses First Patient in Phase III Cell Therapy Trial for Melanoma

News

New York-based Caladrius Biosciences, Inc., a company at the forefront of cell therapy, has recently announced the dosing of the first patient in its Intus Phase III clinical trial. This study intends to ... Read more

July 1, 2015July 1, 2015

New Test For Melanoma Monitoring

News

Researchers from the QIMR Berghofer Medical Research Institute have found new markers for melanoma that have the potential to accurately monitor the disease through a routine blood test. Mitchell Stark, who integrates QIMR Berghofer’s Oncogenomics ... Read more

June 29, 2015July 1, 2015

Recent Discovery Might Lead To Targeted Melanoma Therapies

News

A recent study published in the Molecular Cell journal explains how melanoma patients with higher levels of a specific protein have poorer survival outcomes. The researchers found this particular protein, called H2A.Z.2, ... Read more

June 26, 2015June 26, 2015

Researchers Investigate Novel Treatment for Metastatic Melanoma

News

A collaborative team of international researchers led by Dr. Howard L. Kaufman, MD, FACS, associate director for clinical science and chief surgical officer at Rutgers Cancer Institute of New Jersey, ... Read more

June 19, 2015June 19, 2015

Moffitt Analysis Nivolumab Safety In Melanoma Patients

News

During the the 2015 American Society of Clinical Oncology Annual Meeting in Chicago, Jeffrey S. Weber, M.D., Ph.D., director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt ... Read more

June 17, 2015June 23, 2015

Modified Herpes Virus Increases Survival In Advanced Melanoma Patients

News

In a recent study published in the Journal of Clinical Oncology, University of Louisville researchers along with international colleagues found that patients with stage IIIb to IV melanoma treated with a modified ... Read more

June 15, 2015June 15, 2015

Majority of US Population Does Not Use Sunscreen

News

According to a recent study led by the Centers for Disease Control and Prevention (CDC) and published in the Journal of the American Academy of Dermatology, most people in the United States do not regularly ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group